Search clinical trials for: HPV Vaccine Adherence

Total 14027 results

Wuhan BravoVax Co., Ltd.
Novotech (Australia) Pty Limited; Shanghai BravoBio Co., Ltd.

Not yet recruiting

Phase I Clinical Trial of a Candidate HPV Vaccine

Human Papillomavirus Infection

Australia
The University of Texas Medical Branch, Galveston
Cancer Prevention Research Institute of Texas

Recruiting

Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)

HPV Infection | Human Papillomavirus | Immunization

United States
Masonic Cancer Center, University of Minnesota

Recruiting

Increasing HPV Vaccination in Pediatric, Adolescent, and Young Adult (PAYA) Cancer Survivors

Cancer | HPV Associated Cancer

United States
Western Institute for Veterans Research
Merck Sharp & Dohme LLC; University of Utah

Recruiting

Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts

Warts

United States
Monash University
The Alfred; University of Melbourne

Recruiting

Human Papillomavirus in Young People Epidemiological Research 4 (HYPER4)

Cancer | Anal Cancer | HPV Infection | HPV | Human Papillomavirus Infection | Men | HPV 16 Infection

Australia
Monash University
The Alfred; University of Melbourne

Recruiting

Human Papillomavirus in Young People Epidemiological Research 3 (HYPER3)

Cancer | Anal Cancer | HPV Infection | HPV | Human Papillomavirus Infection | Men | HPV 16 Infection

Australia
Medical College of Wisconsin
Merck Sharp & Dohme LLC

Recruiting

Immunogenicity of HPV Vaccine in Transplant Recipients.

Chronic Kidney Diseases | Kidney Transplant

United States
The Behavioural Insights Team
UNICEF; National Center for Disease Control and Public Health, Georgia; Information...

Not yet recruiting

SMS Reminders to Strengthen Demand for HPV Vaccination in Georgia

HPV, Human Papillomavirus Viruses, Human Papilloma Virus Vaccine
University of British Columbia

Recruiting

A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living With HIV (NOVA-HIV)

Human Immunodeficiency Virus | HPV | Human Papilloma Virus

Canada
Talia Sainz Costa

Recruiting

Immunogenicity of 9-valent HPV Vaccine

Human Papilloma Virus Infection

Spain
Shanghai Bovax Biotechnology Co., Ltd.

Recruiting

Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine

Vaginal Cancer | Cervical Cancer Stage IIa | CIN1 | CIN2 | CIN3 | Genital Wart | HPV Infections

China
Kaiser Permanente
National Cancer Institute (NCI)

Recruiting

Provider Recommendation and HPV Vaccination (HPVV)

Human Papillomavirus

United States
Miquel Angel Pavon Ribas
Catalan Institute of Health; Hospital del Mar

Recruiting

A Study to Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women After Vaccination With 9vHPV (RIFT-HPV) (RIFT-HPV)

Cervical Intraepithelial Neoplasia Grade I/ II/ III (CIN I/II/III) | Human Papillomavirus (HPV) Infections | High-risk HPV | HPV-16/ 18

Spain
McMaster University
Merck Canada Inc.

Recruiting

Assessing Knowledge, Beliefs and Attitudes Toward HPV Vaccination Among Parents in North West, Cameroon

Vaccine Refusal

Cameroon
Zagazig University

Recruiting

Candida Antigen and Bivalent HPV Vaccine in the Treatment of Multiple Warts

Warts | Human Papilloma Virus

Egypt
Louisiana State University Health Sciences Center...
Merck Sharp & Dohme LLC

Recruiting

Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV (AGO-Gard)

Cervical Intraepithelial Neoplasia | Human Immunodeficiency Virus | Anal Intraepithelial Neoplasia | Papillomavirus Infection | Papillomavirus Vaccines | Serology | Oral Cavity Infection

United States
National Vaccine and Serum Institute, China
Sichuan Center for Disease Control and Prevention; Hunan Provincial Center... and other collaborators

Recruiting

A Phase III Clinical Trial of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years

HPV-Related Carcinoma | HPV InfectioN

China
Montefiore Medical Center
National Cancer Institute (NCI); University of Rwanda; Rwanda Military Hospital

Recruiting

HPV Vaccine Effectiveness Study in Rwandan Women Living With HIV

Cervical Cancer | Human Immunodeficiency Virus | HPV-Related Carcinoma | Human Papilloma Virus

Rwanda
Mayo Clinic

Recruiting

A Vaccine (PDS0101) Alone or in Combination With Pembrolizumab for the Treatment of Locally Advanced Human Papillomavirus-Associated Oropharynx Cancer

Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8 | Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8 | Human Papillomavirus-Related Carcinoma | Locally Advanced Oropharyngeal Carcinoma

United States
German Cancer Research Center
University Hospital Heidelberg; National Center for Tumor Diseases, Heidelberg

Recruiting

PANHPVAX, Study of a New HPV Vaccine in Healthy Volunteers (PANHPVAX)

HPV

Germany
International Agency for Research on Cancer
Emory University; Aga Khan University; World Health Organization; University of... and other collaborators

Not yet recruiting

Integration of HPV Vaccination and HPV-based Cervical Screening Into ARV Clinics: the H2VICTORY Trial (H2VICTORY)

HPV Infection
University of Chicago

Recruiting

TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers

Head and Neck Cancer | HPV Positive Oropharyngeal Squamous Cell Carcinoma | HPV | Human Papilloma Virus

United States
University of California, San Francisco

Recruiting

Intralesional HPV Vaccine for Condylomata

Warts | Condylomata Acuminata | Human Papilloma Virus | Warts, Genital | Condyloma

United States
Emory University
National Institute of Nursing Research (NINR)

Recruiting

Advancing HPV Vaccination Among HIV Positive Adults: The CHAMPS Study (CHAMPS)

Human Papilloma Virus | Human Papilloma Virus Vaccine

United States
University of Aarhus
University Clinic for Cancer Screening, Department of Public Health Programmes... and other collaborators

Not yet recruiting

Urinary and Vaginal HPV Testing in Cervical Cancer Screening

Uterine Cervical Neoplasms
Sinocelltech Ltd.

Recruiting

A Phase II Study of SCT1000 in Healthy Women Aged 18 to 45 Years

Randomized | Prevention | Interventional

China
Jun Zhang
Xiamen Innovax Biotech Co., Ltd; Beijing Wantai Biological Pharmacy Enterprise...

Recruiting

The Durability of Protection and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female

Cervical Cancer | Cervical Intraepithelial Neoplasia | Vaginal Intraepithelial Neoplasia | Vulvar Intraepithelial Neoplasia | Persistent Infection

China
Emory University

Recruiting

Assessing Durable Antibody Response to HPV Vaccination

HPV

United States
Shanghai Bovax Biotechnology Co., Ltd.
Chongqing Bovax Biopharmaceutical Co., Ltd.

Recruiting

Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years

Vaginal Cancer | Cervical Cancer Stage IIa | CIN1 | CIN2 | CIN3 | Genital Wart | HPV Infections

China
Jun Zhang
Xiamen Innovax Biotech Co., Ltd; Beijing Wantai Biological Pharmacy Enterprise...

Recruiting

The Durability of Protection Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female

Cervical Cancer | Cervical Intraepithelial Neoplasia | Vaginal Intraepithelial Neoplasia | Vulvar Intraepithelial Neoplasia | Persistent Infection

China
Kenya Medical Research Institute
University of Washington

Not yet recruiting

Effectiveness and B-memory Cell Response to QHPV Vaccine 9-years Post-vaccination Among HIV-infected Boys and Girls

HPV-Related Carcinoma
Sinocelltech Ltd.

Recruiting

A Phase I Safty and Immunogenicity Study of SCT1000 in Healthy Women Aged 18 to 45 Years

HPV Infection Vaccine Safety SCT1000

China
Shanghai Bovax Biotechnology Co., Ltd.
Chongqing Bovax Biopharmaceutical Co., Ltd.

Recruiting

Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years

Cervical Cancer | Vulvar Cancer | Vaginal Cancer | CIN1 | CIN2 | VaIN1 | VaIN2 | VaIN3 | Genital Wart | VIN 1 | VIN 2 | VIN 3 | AIS | HPV Infections | CIN 3

China
Assistance Publique - Hôpitaux de Paris

Recruiting

Nonavalent HPV Vaccine in the Treatment of Difficult-to-treat Palmo-plantar Warts (VAC-WARTS)

Palmar or Plantar Warts

France
University of Colorado, Denver
National Cancer Institute (NCI); National Institutes of Health (NIH)

Recruiting

The HPV 9-10 Trial: Early Initiation of HPV Vaccination

HPV

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
PapiVax Biotech, Inc.

Recruiting

Safety and Efficacy of Allogeneic HPV-specific T Cells in Adults With Recurrent or Metastatic HPV16+ Cancers

HPV 16+ Recurrent or Metastatic Cancer

United States
BioNTech SE

Recruiting

A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1 (AHEAD-MERIT)

Recurrent Head and Neck Cancer | Unresectable Head and Neck Squamous Cell Carcinoma | Metastatic Head and Neck Cancer

Germany, United States, France, United Kingdom, Korea, Republic of, Spain, Poland, Belgium, Brazil, Taiwan, Italy, Canada, Czechia, Australia, Turkey, Mexico, Chile, Argentina, Austria, Hungary, Portugal, Sweden
University of Alabama at Birmingham
National Cancer Institute (NCI)

Recruiting

Provider-Focused Intervention for Maximizing HPV Vaccine Uptake in Young Cancer Survivors

Papillomavirus Vaccines

United States
Chinese University of Hong Kong

Recruiting

HPV Vaccination Health-promotion Programme on Vaccine Acceptance and Uptake Among Female Adolescents

Health Attitude | Health Behavior | HPV Infection

Hong Kong
Shanghai Bovax Biotechnology Co., Ltd.

Recruiting

Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

Cervical Cancer | Vulvar Cancer | Vaginal Cancer | CIN1 | CIN2 | CIN3 | VaIN1 | VaIN2 | VaIN3 | Genital Wart | VIN 1 | VIN 2 | VIN 3 | AIS

China
Meharry Medical College

Recruiting

A Tailored, Health Communication Intervention for HPV Vaccine Hesitant Families

Parents | HPV-Related Carcinoma | Human Papilloma Virus | Vaccine Refusal | Program, Communication

United States
Dan Zandberg
Merck Sharp & Dohme LLC; ISA Pharmaceuticals

Recruiting

HPV-16 Vaccination and Pembrolizumab Plus Cisplatin for "Intermediate Risk" HPV-16-associated Head and Neck Squamous Cell Carcinoma

Head and Neck Squamous Cell Carcinoma | HPV-Related Squamous Cell Carcinoma

United States
University of Colorado, Denver
National Cancer Institute (NCI); National Institutes of Health (NIH)

Recruiting

Engaging Practices and Communities in the Development of Interventions to Promote HPV Vaccine Uptake

Primary Prevention

United States
Boston Medical Center
Merck Sharp & Dohme LLC

Recruiting

An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen

HPV Infection

United States
Hookipa Biotech GmbH

Recruiting

A Phase 1/2 Study in Patients With HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Other Cancers

HPV-Related Squamous Cell Carcinoma

United States, Spain, Netherlands
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Recruiting

HPV DNA Vaccine Via Electroporation for HPV16 Positive Cervical Neoplasia

Human Papillomavirus Type 16 | Cervical Intraepithelial Neoplasia Grade II | Cervical Intraepithelial Neoplasia, Grade III

United States
Imperial College London

Not yet recruiting

Nonavalent Prophylactic HPV Vaccine (GARDASIL9) After Local Conservative The NOVEL Trial (NOVEL)

Neoplasia
University Health Network, Toronto
Merck Sharp & Dohme LLC

Not yet recruiting

HPV-SAVE_Merck_Sub-Study for Preventing Recurrence of HSIL

Anal Cancer | Human Papilloma Virus | Anal Intraepithelial Neoplasia

Canada
Alessandro Ghelardi

Not yet recruiting

Impact on Disease Relapse of HPV Vaccination in Women Treated With LEEP for Cervical Intraepithelial Neoplasia. HOPE9 (HOPE9)

Cervical Intraepithelial Neoplasia
University of Florida
Patient-Centered Outcomes Research Institute; National Cancer Institute (NCI)

Not yet recruiting

Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial

Human Papillomavirus (HPV) Vaccines

United States

Search clinical trials for: HPV Vaccine Adherence

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritius

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations